SUBSCRIBE
SUBSCRIBE

Phase 1

Drug Development
Why 2017 Will be a Data-Rich and Not Revenue-Focused Year for bluebird bio
February 24, 2017
 · 
1 min read
Drug Development
Could Marijuana Be the Next Miracle Drug For Treating Cancer?
February 20, 2017
 · 
1 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
3 Biotechs With the Biggest and Most Promising Pipelines
February 16, 2017
 · 
2 min read
Drug Development
Allergan R&D Chief Reveals 6 Drugs That Could be Potential Blockbusters
February 14, 2017
 · 
1 min read
No Looking Back: Cellectis Preps for Cutting-Edge 'Off-the-Shelf' CAR-T Trial
Drug Development
No Looking Back: Cellectis Preps for Cutting-Edge ‘Off-the-Shelf’ CAR-T Trial
February 7, 2017
 · 
2 min read
GlaxoSmithKline CEO Kills 30+ Pre-Clinical and Clinical Programs
Drug Development
GlaxoSmithKline’s Incoming CEO Preps for Deals, R&D Decisions on New Drugs
February 6, 2017
 · 
2 min read
Drug Development
5 Daring Biopharmas Mixing Drugs With Marijuana
February 6, 2017
 · 
1 min read
Drug Development
NASA Sent One Identical Twin Brother To Space And Studied How It Changed Him—Here Are The First Results
February 3, 2017
 · 
1 min read
3 Biotechs That Could be Taken Out This Quarter
Drug Development
These 5 Biotechs Are Battling Over the $10 Billion Hemophilia Market
February 3, 2017
 · 
3 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
Catabasis Plunges on DMD Drug Trial Failure
February 1, 2017
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
Ernexa Therapeutics CEO Corner Highlights Differentiated ERNA-101 Platform as Company Advances Toward Planned First-in-Human Phase 1 Study in 2026
July 14, 2026
 · 
5 min read
Press Releases
Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus
July 14, 2026
 · 
7 min read
Press Releases
Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026
July 14, 2026
 · 
6 min read
Press Releases
Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury
July 14, 2026
 · 
3 min read
Press Releases
Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome
July 14, 2026
 · 
8 min read
Press Releases
Erasca Announces Updated Preliminary Phase 1 Data and Registration-Enabling Plans for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors
July 13, 2026
 · 
9 min read
Press Releases
Zelluna doses first solid tumour patient with ZI-MA4-1 in the ZIMA-101 Phase 1 trial
July 13, 2026
 · 
4 min read
Press Releases
Ollin Biosciences Announces Upcoming Presentations of OLN324 Data in Diabetic Macular Edema and Wet Age-Related Macular Degeneration at the American Society of Retina Specialists (ASRS) 44th Annual Scientific Meeting
July 13, 2026
 · 
2 min read
Press Releases
Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
July 13, 2026
 · 
5 min read
Press Releases
Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes
July 13, 2026
 · 
9 min read
Press Releases
Incyte Presents Phase 1/2 Multidose Data for VGA039 (Latarcibart) at ISTH 2026, Showing Substantial Bleed Reductions in Patients with all Von Willebrand Disease Types
July 13, 2026
 · 
8 min read
Press Releases
New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases
July 13, 2026
 · 
4 min read
Press Releases
Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
July 9, 2026
 · 
7 min read
Press Releases
Astellas to Spotlight New Research for Geographic Atrophy at ASRS 2026 Annual Meeting
July 9, 2026
 · 
9 min read
Press Releases
IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma
July 9, 2026
 · 
7 min read
Press Releases
Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGx-BEST1 Results
July 9, 2026
 · 
7 min read
Press Releases
Blue Earth Therapeutics announces first participant dosed in Phase 1 clinical trial investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in metastatic castration-resistant prostate cancer
July 9, 2026
 · 
6 min read
Press Releases
Kenai Therapeutics Announces Completion of Enrollment in Phase 1b/2a REPLACE™ Trial of RNDP-001 in Idiopathic Parkinson’s Disease
July 7, 2026
 · 
4 min read
Press Releases
FibroBiologics Completes Manufacturing of Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
July 7, 2026
 · 
5 min read
Press Releases
Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd
July 7, 2026
 · 
5 min read
Load More